Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3)

by Assanatham, M., Boongird, S., Bruminhent, J., Chuengsaman, P., Kiertiburanakul, S., Kitpermkiat, R., Malathum, K., Nongnuch, A., Phuphuakrat, A., Prasongtanakij, S., Setthaudom, C., Srisala, S.
Published 2022